267 related articles for article (PubMed ID: 25265366)
1. Vaginal suppositories containing Lactobacillus acidophilus: development and characterization.
Rodrigues F; Maia MJ; das Neves J; Sarmento B; Amaral MH; Oliveira MB
Drug Dev Ind Pharm; 2015; 41(9):1518-25. PubMed ID: 25265366
[TBL] [Abstract][Full Text] [Related]
2. In-vitro evaluation and vaginal absorption of metronidazole suppositories in rabbits.
Ozyazici M; Turgut EH; Taner MS; Köseoglu K; Ertan G
J Drug Target; 2003 Apr; 11(3):177-85. PubMed ID: 14577974
[TBL] [Abstract][Full Text] [Related]
3. Development and evaluation of a suppository formulation containing Lactobacillus and its application in vaginal diseases.
Kale VV; Trivedi RV; Wate SP; Bhusari KP
Ann N Y Acad Sci; 2005 Nov; 1056():359-65. PubMed ID: 16387701
[TBL] [Abstract][Full Text] [Related]
4. Enteric coating of granules containing the probiotic Lactobacillus acidophilus.
Pyar H; Peh KK
Acta Pharm; 2014 Jun; 64(2):247-56. PubMed ID: 24914724
[TBL] [Abstract][Full Text] [Related]
5. Development and characterization of a solid dispersion film for the vaginal application of the anti-HIV microbicide UAMC01398.
Grammen C; Van den Mooter G; Appeltans B; Michiels J; Crucitti T; Ariën KK; Augustyns K; Augustijns P; Brouwers J
Int J Pharm; 2014 Nov; 475(1-2):238-44. PubMed ID: 25175729
[TBL] [Abstract][Full Text] [Related]
6. Effect of drug solubility on in vitro availability rate from suppositories with polyethylene glycol excipients.
Realdon N; Ragazzi E; Ragazzi E
Pharmazie; 2001 Feb; 56(2):163-7. PubMed ID: 11234347
[TBL] [Abstract][Full Text] [Related]
7. A gastro-resistant ovalbumin bi-layered mini-tablet-in-tablet system for the delivery of Lactobacillus acidophilus probiotic to simulated human intestinal and colon conditions.
Govender M; Choonara YE; van Vuuren S; Kumar P; du Toit LC; Pillay V
J Pharm Pharmacol; 2015 Jul; 67(7):939-50. PubMed ID: 25645491
[TBL] [Abstract][Full Text] [Related]
8. Suppository formulations as a potential treatment for nephropathic cystinosis.
Buchan B; Kay G; Matthews KH; Cairns D
J Pharm Sci; 2012 Oct; 101(10):3729-38. PubMed ID: 22778070
[TBL] [Abstract][Full Text] [Related]
9. Formulation and Optimization of Metronidazole and
Ilomuanya MO; Salako BB; Ologunagba MO; Shonekan OO; Owodeha-Ashaka K; Osahon ES; Amenaghawon AN
Pharmaceutics; 2022 Oct; 14(11):. PubMed ID: 36365154
[TBL] [Abstract][Full Text] [Related]
10. Sildenafil vaginal suppositories: preparation, characterization, in vitro and in vivo evaluation.
Shanmugam S; Kim YH; Park JH; Im HT; Sohn YT; Kim KS; Kim YI; Yong CS; Kim JO; Choi HG; Woo JS
Drug Dev Ind Pharm; 2014 Jun; 40(6):803-12. PubMed ID: 23781859
[TBL] [Abstract][Full Text] [Related]
11. Rapidly disintegrating vagina retentive cream suppositories of progesterone: development, patient satisfaction and in vitro/in vivo studies.
Bendas ER; Basalious EB
Pharm Dev Technol; 2016; 21(3):288-95. PubMed ID: 25567033
[TBL] [Abstract][Full Text] [Related]
12. Dissolution and vaginal absorption characteristics of metronidazole and ornidazole.
Ozyazici M; Gökçe E; Hizarcioglu SY; Taner MS; Köseoglu K; Ertan G
Pharmazie; 2006 Oct; 61(10):855-61. PubMed ID: 17069425
[TBL] [Abstract][Full Text] [Related]
13. Effect of some pharmaceutical excipients on the survival of probiotic vaginal lactobacilli.
Zárate G; Tomás MS; Nader-Macias ME
Can J Microbiol; 2005 Jun; 51(6):483-9. PubMed ID: 16121226
[TBL] [Abstract][Full Text] [Related]
14. Freeze-dried mucoadhesive polymeric system containing pegylated lipoplexes: Towards a vaginal sustained released system for siRNA.
Furst T; Dakwar GR; Zagato E; Lechanteur A; Remaut K; Evrard B; Braeckmans K; Piel G
J Control Release; 2016 Aug; 236():68-78. PubMed ID: 27329774
[TBL] [Abstract][Full Text] [Related]
15. The vaginal sheet: an innovative form of vaginal film for the treatment of vaginal infections.
Machado RM; Tomás M; Palmeira-de-Oliveira A; Martinez-de-Oliveira J; Palmeira-de-Oliveira R
Drug Dev Ind Pharm; 2020 Jan; 46(1):135-145. PubMed ID: 31893929
[No Abstract] [Full Text] [Related]
16. Preparation and in vitro evaluation of vaginal formulations including siRNA and paclitaxel-loaded SLNs for cervical cancer.
Büyükköroğlu G; Şenel B; Başaran E; Yenilmez E; Yazan Y
Eur J Pharm Biopharm; 2016 Dec; 109():174-183. PubMed ID: 27793757
[TBL] [Abstract][Full Text] [Related]
17. Pediatric suppositories of sulpiride solid dispersion for treatment of Tourette syndrome: in vitro and in vivo investigations.
Zidan AS; Emam SE; Shehata TM; Ghazy FE
AAPS PharmSciTech; 2015 Jun; 16(3):645-55. PubMed ID: 25501871
[TBL] [Abstract][Full Text] [Related]
18. [Study of vaginal and intestinal microflora of women in the prenatal period and its correction in dysbacteriosis].
Podgorskiĭ VS; Liaskovskiĭ TM; Kovalenko NK; Oleshchenko LT
Mikrobiol Z; 2006; 68(2):92-104. PubMed ID: 16786633
[TBL] [Abstract][Full Text] [Related]
19. Preparation and characterization of intravaginal vardenafil suppositories targeting a complementary treatment to boost in vitro fertilization process.
Gomaa E; Abu Lila AS; Hasan AA; Ghazy FS
Eur J Pharm Sci; 2018 Jan; 111():113-120. PubMed ID: 28964952
[TBL] [Abstract][Full Text] [Related]
20. A pilot study evaluating the safety and effectiveness of Lactobacillus vaginal suppositories in patients with recurrent urinary tract infection.
Uehara S; Monden K; Nomoto K; Seno Y; Kariyama R; Kumon H
Int J Antimicrob Agents; 2006 Aug; 28 Suppl 1():S30-4. PubMed ID: 16859900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
